Protocol consisting of cisplatin, etoposide and irinotecan induced complete pathological remission of primary small cell carcinoma of the bladder.

Kawahara T; Nishiyama H; Yamamoto S; Kamoto T; Ogawa O

首页> 外文期刊>International journal of urology: official journal of the Japanese Urological Association >Protocol consisting of cisplatin, etoposide and irinotecan induced complete pathological remission of primary small cell carcinoma of the bladder.

【24h】

Protocol consisting of cisplatin, etoposide and irinotecan induced complete pathological remission of primary small cell carcinoma of the bladder.

机译：由顺铂，依托泊苷和伊立替康组成的协议可诱导原发性膀胱小细胞癌完全病理缓解。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

A 73-year-old man with primary small-cell carcinoma of the bladder was treated by radical cystectomy with neoadjuvant chemotherapy. Pathological complete remission was achieved by combination chemotherapy composed of cisplatin, etoposide and irinotecan. The patient is free of disease 19 months after surgery.

机译：一位73岁的原发性膀胱小细胞癌男子接受了根治性膀胱切除术并辅以新辅助化疗。顺铂，依托泊苷和伊立替康联合化疗可达到病理完全缓解。手术后19个月，患者没有疾病。

著录项

来源
《International journal of urology: official journal of the Japanese Urological Association》 |2006年第9期|共3页
作者
Kawahara T; Nishiyama H; Yamamoto S; Kamoto T; Ogawa O;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词
Carcinoma of bladder; irinotecan; Etoposide; Cisplatin; Cells; 依托泊甙; 顺铂; 细胞;

机译：Carcinoma of bladder;irinotecan;Etoposide;Cisplatin;Cells;依托泊甙;顺铂;细胞;

相似文献

外文文献
中文文献
专利

1. Protocol consisting of cisplatin, etoposide and irinotecan induced complete pathological remission of primary small cell carcinoma of the bladder. [J] . Kawahara T, Nishiyama H, Yamamoto S, International journal of urology: official journal of the Japanese Urological Association . 2006,第9期

机译：由顺铂，依托泊苷和伊立替康组成的协议可诱导原发性膀胱小细胞癌完全病理缓解。
2. Complete remission of ovarian small cell carcinoma treated with irinotecan and cisplatin: a case report. [J] . Saitoh-Sekiguchi M, Nakahara K, Kojimahara T, Anticancer Research: International Journal of Cancer Research and Treatment . 2007,第4C期

机译：用伊立替康和顺铂治疗的卵巢小细胞癌完全缓解：一例。
3. Nivolumab plus gemcitabine, dexamethasone, and cisplatin chemotherapy induce durable complete remission in relapsed/refractory primary mediastinal B-cell lymphoma: a case report and literature review [J] . Gang Huang, Ju Huang, Zhili Zhang, Journal of International Medical Research . 2020,第8期

机译：Nivolumab Plus Gemcitabine，地塞米松和顺铂化疗诱导复发/难治原发性纵隔B细胞淋巴瘤的耐用完全缓解：案例报告和文献综述
4. THE INHIBITION OF N-LINKED GLYCOSYLATION BREAKS THE RESISTANACE OF HUMAN OVARIAN CANCER CELLS TO CISPLATIN AND ETOPOSIDE [C] . Anna Macieia, Joanna Sarnik, Zbigniew J. Witczak International Carbohydrate Symposium . 2018

机译：N-连接的糖基化的抑制破坏了人卵巢癌细胞对顺铂和依托泊苷的抗性
5. E3 Ligase Identified by Differential Display (EDD) Enhances Cell Survival and Cisplatin Resistance in Epithelial Ovarian Cancer and Oral Squamous Cell Carcinoma. [D] . Bradley, Amber Thompson. 2014

机译：通过差异显示（EDD）鉴定的E3连接酶可增强上皮性卵巢癌和口腔鳞状细胞癌的细胞存活率和顺铂耐药性。
6. Second-line chemotherapy for refractory small cell neuroendocrine carcinoma of the esophagus that relapsed after complete remission with irinotecan plus cisplatin therapy: Case report and review of the literature [O] . SHINSUKE FUNAKOSHI, AKINORI HASHIGUCHI, KANA TERAMOTO, -1

机译：伊立替康联合顺铂治疗完全缓解后食管难治性食管小细胞神经内分泌癌的二线化疗：病例报告及文献复习
7. Complete remission of refractory small cell carcinoma of the pancreas with cisplatin and etoposide [O] . Rudolf Morant, Howard W. Bruckner 1989

机译：完全缓解胰腺和依托普齐苷的胰腺难治性小细胞癌

Protocol consisting of cisplatin, etoposide and irinotecan induced complete pathological remission of primary small cell carcinoma of the bladder.

摘要

著录项

相似文献

相关主题

期刊订阅